CAT Project: Boyce Thompson Inst researcher Joyce Van Eck and corporate partner Ascribe are working to develop technology that will expedite the process of identifying and developing natural molecule-based products for agricultural sustainability biotech.cornell.edu/commercializat…

futurology.life/46-most-innova…

#GrowNY winner Ascribe has expounded upon its novel seed treatment technology since winning $500,000 at the 2021 summit, having closed a $2.5 million seed round in November and landing a $3 million NIAID SBIR Phase II award this spring. Learn more at ascribebio.com.

I-Corps alumni Ascribe was recently awarded $3 million in NIH SBIR funding for its novel seed treatment technology. The startup’s #innovation makes edible sprouts and microgreens safer for consumers. Learn more: bit.ly/3zh6frJ

Wrapping up 2 days of visiting field trials across OH & KY for Ascribe. Here are wheat plots University of Kentucky Martin-Gatton CAFE research station in Princeton, KY.

Nothing like seeing differences in the field! Side-by-side KY soybean plots with & without Ascribe biological seed treatment.

Congratulations to I-Corps Ascribe for being awarded a $3 million NIH SBIR Phase II award! The #startup will use the funding to study its seed treatment technology, which prevents bacterial contamination in edible sprouts and microgreens. Learn more: bit.ly/3zh6frJ

Thanks Regenerative Food Systems Investment for highlighting Ascribe this week rfsi-forum.com/meet-the-activ…

Sometimes it's hard to tell if a new ag product works. Not in this trial. Ascribe saving pumpkins for Halloween

Excited to try a new powdered formulation of Phytalix biofungicide in our R&D

Big milestone on our journey to bring better disease control options to farmers Boyce Thompson Inst businesswire.com/news/home/2023…

Big deal - Ascribe has entered into a development agreement with Loveland Products to launch biofungicides for row crops. #agtech croplife.com/crop-inputs/lo…

BTI is proud to announce that Ascribe, a company founded on BTI technology, has partnered with Nutrien Ag Solutions to commercialize two crop protection products containing Ascribe’s flagship biofungicide, Phytalix®. btiscience.org/explore-bti/ne…

Thanks Upstream Ag for highlighting Ascribe this week in the article on the future of biocontrol

frontiersin.org/news/2024/10/1…

Starting our 4th season of field trials in South America for Phytalix biofungicide. Pic taken yesterday in Paraguay. While the applicator is decked out in standard PPE, Phytalix is non-toxic & offers growers a safe, new option for disease control.

Steadily gearing up to launch our biofungicide, Ascribe welcomes new investor ICIG ic-investors.com/news/icig-vent…

New sustainable disease control options in Rice from Ascribe forbes.com/sites/daphneew…